✦ LIBER ✦

Effects of low dose total body irradiation (LDTBI) and recombinant human interleukin-2 in mice

✍ Scribed by Fourquet, A.; Teillaud, J.-L.; Lando, D.; Fridman, W.-H.

Book ID: 123123830
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 747 KB
Volume: 26
Category: Article
ISSN: 0167-8140
DOI: 10.1016/0167-8140(93)90263-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of low-dose total body

A phase II trial of low-dose total body irradiation and subcutaneous Interleukin-2 in metastatic melanoma

✍ Akmal Safwat; Henrik Schmidt; Lars Bastholt; Kirsten Fode; Susanne Larsen; Ninna 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Low-dose total body irradiation augments

Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma

✍ Akmal Safwat; Ninna Aggerholm; Ivan Roitt; Jens Overgaard; Marianne Hokland 📂 Article 📅 2003 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 152 KB

Immunomodulatory effects of systemic low

Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans

✍ Timothy J. Eberlein; Mary L. Rodrick; Anthony F. Massaro; Sung-Eun Jung; John A. 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 799 KB

Anti-tumor effects of local irradiation

Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2)

✍ I.-M. Jürgenliemk-Schulz; I.B. Renes; D.H. Rutgers; L.A. Everse; M.R. Bernsen; W 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

The aim of this work was to improve radiotherapy results by immune stimulation. We tested the effects of a combination of radio-and immunotherapy, i.e., local low dose recombinant interleukin-2 (rIL-2) treatment, in two murine tumor models. Syngeneic tumors (SL2 lymphoma or M8013 mammary carcinoma)

Antitumor effect of locally injected low

Antitumor effect of locally injected low doses of recombinant human interleukin-2 in bovine vulval papilloma and carcinoma

✍ F.W.G. Hill; W.R. Klein; M.J. Hoyer; V.P.M.G. Rutten; N. Kock; J.W. Koten; P.A. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 629 KB

The synergistic antitumor effect of reco

The synergistic antitumor effect of recombinant interleukin-1 and low-dose of cyclophosphamide in tumor-bearing mice

✍ Takehisa Harada; Norimichi Kan; You Ichinose; Yoshio Moriguchi; Li Li; Tomoharu 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

## Abstract Intraperitoneal (i. p.) treatment of MOPC104E ascitic tumor‐bearing BALB/c mice with interleukin‐1 (IL‐1) followed by a low dose of cyclophosphamide (CPA) resulted in synergistic prolongation of their survival time. This antitumor effect was abolished when administration of CPA preceded